PEPTONIC medical AB (publ)

DB:28L Stock Report

Market Cap: €29.6m

PEPTONIC medical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Anna Linton

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.004%
Management average tenureno data
Board average tenure1.4yrs

Recent management updates

Recent updates


CEO

Anna Linton (53 yo)

less than a year

Tenure

Ms. Anna Linton is Chief Executive Officer of Pharmiva AB (publ) from August 2022. She is Chief Executive Officer since February 06, 2024 at PEPTONIC medical AB (publ). She has several years of experience...


Board Members

NamePositionTenureCompensationOwnership
Tarek Shoeb
Director1.8yrsSEK 117.00k0.76%
€ 226.6k
Anders Blom
Chairman of the Board1.4yrsSEK 229.00k4.08%
€ 1.2m
Kristina Ingvar
Directorless than a yearno data0.0083%
€ 2.5k
Mika Kurjanen
Board Member Lune Group Oy Ltdno datano datano data
Daniel Rudeklint
Directorno dataSEK 200.00k0.0080%
€ 2.4k

1.4yrs

Average Tenure

53.5yo

Average Age

Experienced Board: 28L's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.